Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04875169 · COMPLETED
Trial details
- NCT number
- NCT04875169
- Sponsor
- Reistone Biopharma Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2022-08-12
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.